Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas-Reference-Cited by-同舟云学术

Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas

Published:2007 Issue:4 Volume:109 Page:741-750
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ohtsuka Kouki,Ohnishi Hiroaki,Fujiwara Masachika,Kishino Tomonori,Matsushima Satsuki,Furuyashiki Go,Takei Hidefumi,Koshiishi Yoshihiko,Goya Tomoyuki,Watanabe Takashi

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

1. Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

2. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

3. Epidermal Growth Factor Receptor Mutations and Gene Amplification in Non–Small-Cell Lung Cancer: Molecular Analysis of the IDEAL/INTACT Gefitinib Trials

4. Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers

5. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current management of uncommon EGFR mutations in non-small cell lung cancer;Current Problems in Cancer;2024-04

2. Molecular Pathogenesis of Lung Cancer: Evolving Landscapes Based on Past Experience;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

3. Adenosquamous Carcinoma;Diagnostic Imaging of Lung Cancers;2023

4. Novel targeted therapies for advanced non-small lung cancer;Seminars in Oncology;2022-06

5. How should molecular findings be integrated in the classification for lung cancer?;Translational Lung Cancer Research;2020-10